<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0036-3634</journal-id>
<journal-title><![CDATA[Salud Pública de México]]></journal-title>
<abbrev-journal-title><![CDATA[Salud pública Méx]]></abbrev-journal-title>
<issn>0036-3634</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Salud Pública]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0036-36342003000400002</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Information from teachers on viral hepatitis transmission and prevention in Brazil]]></article-title>
<article-title xml:lang="es"><![CDATA[Información de los maestros sobre la transmisión y la prevención de las hepatitis virales en el Brasil]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gaze]]></surname>
<given-names><![CDATA[Rosangela]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[Diana Maul de]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rangel-Tura]]></surname>
<given-names><![CDATA[Luiz Fernando]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Rio de Janeiro Federal University Public Health Nucleus State Ministry of Health Brazil's Ministry of Health]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Rio de Janeiro Federal University Public Health Nucleus Preventive Medicine Department ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brazil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2003</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2003</year>
</pub-date>
<volume>45</volume>
<numero>4</numero>
<fpage>245</fpage>
<lpage>251</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0036-36342003000400002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0036-36342003000400002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0036-36342003000400002&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[OBJECTIVE: To assess school teachers' level of knowledge on prevention of viral hepatitis (VH). MATERIAL AND METHODS: A cross-sectional study was conducted in three cities of Brazil, from August to November of 1999. The sample was composed of 360 subjects: 334 women and 26 men, 81 (22.5%) from Belém, 123 (34.2%) from Natal and 156 (43.3%) from Rio de Janeiro. Cultural differences in knowledge were identified using a questionnaire to classify, according to semantic content, categories of transmission and preventive practices. Responses were scored as right or wrong. Data were tabulated and analyzed using EPIINFO 6.04 and open answers were classified according to semantic content. Comparison of the answer frequencies between cities was done through the chi-square test. RESULTS: Transmission category (TC) (n=837 answers) and prevention category (PC) (n=771 answers) "food-and waterborne" transmission items were the most frequently mentioned (40%). For TC, "food-and waterborne" answers were followed by "bloodborne" (16%), "inadequate knowledge" (9%), "possible causes of hepatic disease" (9%), and "sexual transmission" (7%) answers. For PC items, "food-and waterborne" answers were followed by "general aspects of prevention" (13%), "immunization" (9%), "quality of health services" (8%) and "sexual prevention" (5%) items. "Right" scores for transmission mechanisms and prevention practices varied from zero to 80%. CONCLUSIONS: Study findings suggest that investments should be made to disseminate appropriate knowledge on VH prevention, mainly addressing sexual transmission and intravenous drug use.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[OBJETIVO: Evaluar los conocimientos y prácticas de profesores escolares en la prevención de hepatitis viral. MATERIAL Y MÉTODOS: Se llevó a cabo un estudio transversal en tres ciudades de Brasil, de agosto a noviembre de 1999. La muestra estuvo constituida por 360 sujetos: 334 mujeres y 26 hombres, 81 (22.5%) de Belém, 123 (34.2%) de Nataly 156 (43.3%) de Río de Janeiro. Se determinaron diferencias culturales en cuanto a conocimientos, prácticas y actitudes. Se utilizó un cuestionario clasificado según su contenido semántico en categorías de transmisión y prácticas preventivas; las respuestas se evaluaron como "errores" y "aciertos". Los datos se tabularon y analizaron usando EPIINFO 6.4, y las respuestas abiertas se clasificaron de acuerdo con el contenido semántico. La comparación de las frecuencias de las respuestas entre las ciudades se hizo mediante ji cuadrada. RESULTADOS: En 837 respuestas en la categoría transmisión y 771 en prevención, la comida y el agua fueron las más frecuentemente citadas (40%). En transmisión, las respuestas subsecuentes fueron, en orden de frecuencia: transfusión de sangre (16%), conocimiento inadecuado (9%), causas posibles de enfermedades hepáticas (9%) y transmisión sexual (7%). En prevención, las respuestas subsecuentes fueron, en orden de frecuencia: aspectos generales de prevención (13%), inmunización (9%), calidad de los servicios de salud (8%) y prevención sexual (5%). El número de "aciertos" sobre mecanismos de transmisión y prácticas de prevención varió entre 0 y 80%. CONCLUSIONES: Los resultados sugieren que se debe invertir más en la difusión de conocimientos sobre hepatitis viral, su transmisión sexual y por el uso de drogas inyectables.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[hepatitis]]></kwd>
<kwd lng="en"><![CDATA[hepatitis]]></kwd>
<kwd lng="en"><![CDATA[awarenes]]></kwd>
<kwd lng="en"><![CDATA[prevention practices]]></kwd>
<kwd lng="en"><![CDATA[Brazil]]></kwd>
<kwd lng="es"><![CDATA[hepatitis viral]]></kwd>
<kwd lng="es"><![CDATA[conocimiento]]></kwd>
<kwd lng="es"><![CDATA[prácticas preventivas]]></kwd>
<kwd lng="es"><![CDATA[Brasil]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><b><font size="2" face="Verdana">ART&Iacute;CULO ORIGINAL</font></b></p>     <p>&nbsp;</p>     <p><font size="4" face="Verdana"><b>Information from teachers on viral hepatitis    transmission and prevention in Brazil</b></font> </p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana"><b>Informaci&oacute;n de los maestros sobre la    transmisi&oacute;n y la prevenci&oacute;n de las hepatitis virales en el Brasil</b></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"><b>Rosangela Gaze, MD, MPh<sup>I</sup>; Diana    Maul de Carvalho, MD, DSc<sup>II</sup>; Luiz Fernando Rangel-Tura, MD, DSc<sup>II</sup></b></font></p>     <p><font size="2" face="Verdana"><sup>I</sup>Rio de Janeiro Federal University    Public Health Nucleus; Rio de Janeiro State Ministry of Health and Brazil's    Ministry of Health, Brazil    <br>   <sup>II</sup>Preventive Medicine Department and Rio de Janeiro Federal University    Public Health Nucleus, Brazil</font></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p>&nbsp;</p> <HR size="1" noshade>     <p><font size="2" face="Verdana"><b>ABSTRACT</b> </font></p>     <p><font size="2" face="Verdana"><B>OBJECTIVE:</B> To assess school teachers' level    of knowledge on prevention of viral hepatitis (VH). <B>    <br>   MATERIAL AND METHODS:</B> A cross-sectional study was conducted in three cities    of Brazil, from August to November of 1999. The sample was composed of 360 subjects:    334 women and 26 men, 81 (22.5%) from Bel&eacute;m, 123 (34.2%) from Natal and    156 (43.3%) from Rio de Janeiro. Cultural differences in knowledge were identified    using a questionnaire to classify, according to semantic content, categories    of transmission and preventive practices. Responses were scored as right or    wrong. Data were tabulated and analyzed using EPIINFO 6.04 and open answers    were classified according to semantic content. Comparison of the answer frequencies    between cities was done through the chi-square test.    <br>   <B>RESULTS:</B> Transmission category (TC) (n=837 answers) and prevention category    (PC) (n=771 answers) &quot;food-and waterborne&quot; transmission items were    the most frequently mentioned (40%). For TC, &quot;food-and waterborne&quot;    answers were followed by &quot;bloodborne&quot; (16%), &quot;inadequate knowledge&quot;    (9%), &quot;possible causes of hepatic disease&quot; (9%), and &quot;sexual    transmission&quot; (7%) answers. For PC items, &quot;food-and waterborne&quot;    answers were followed by &quot;general aspects of prevention&quot; (13%), &quot;immunization&quot;    (9%), &quot;quality of health services&quot; (8%) and &quot;sexual prevention&quot;    (5%) items. &quot;Right&quot; scores for transmission mechanisms and prevention    practices varied from zero to 80%.     <br>   <B>CONCLUSIONS:</B> Study findings suggest that investments should be made to    disseminate appropriate knowledge on VH prevention, mainly addressing sexual    transmission and intravenous drug use. The English version of this paper is    available too at: <a href="http://www.insp.mx/salud/index.html">http://www.insp.mx/salud/index.html</a></font></p>     <p><font size="2" face="Verdana"><b>Key words:</b> hepatitis, viral, human; awarenes;    prevention practices; Brazil</font></p> <hr size="1" noshade>     <p><b><font size="2" face="Verdana">RESUMEN</font></b></p>     <p><font size="2" face="Verdana"><B>OBJETIVO:</B> Evaluar los conocimientos y    pr&aacute;cticas de profesores escolares en la prevenci&oacute;n de hepatitis    viral.     ]]></body>
<body><![CDATA[<br>   <B>MATERIAL Y M&Eacute;TODOS:</B> Se llev&oacute; a cabo un estudio transversal    en tres ciudades de Brasil, de agosto a noviembre de 1999. La muestra estuvo    constituida por 360 sujetos: 334 mujeres y 26 hombres, 81 (22.5%) de Bel&eacute;m,    123 (34.2%) de Nataly 156 (43.3%) de R&iacute;o de Janeiro. Se determinaron    diferencias culturales en cuanto a conocimientos, pr&aacute;cticas y actitudes.    Se utiliz&oacute; un cuestionario clasificado seg&uacute;n su contenido sem&aacute;ntico    en categor&iacute;as de transmisi&oacute;n y pr&aacute;cticas preventivas; las    respuestas se evaluaron como &quot;errores&quot; y &quot;aciertos&quot;. Los    datos se tabularon y analizaron usando EPIINFO 6.4, y las respuestas abiertas    se clasificaron de acuerdo con el contenido sem&aacute;ntico. La comparaci&oacute;n    de las frecuencias de las respuestas entre las ciudades se hizo mediante ji    cuadrada.     <br>   <B>RESULTADOS:</B> En 837 respuestas en la categor&iacute;a transmisi&oacute;n    y 771 en prevenci&oacute;n, la comida y el agua fueron las m&aacute;s frecuentemente    citadas (40%). En transmisi&oacute;n, las respuestas subsecuentes fueron, en    orden de frecuencia: transfusi&oacute;n de sangre (16%), conocimiento inadecuado    (9%), causas posibles de enfermedades hep&aacute;ticas (9%) y transmisi&oacute;n    sexual (7%). En prevenci&oacute;n, las respuestas subsecuentes fueron, en orden    de frecuencia: aspectos generales de prevenci&oacute;n (13%), inmunizaci&oacute;n    (9%), calidad de los servicios de salud (8%) y prevenci&oacute;n sexual (5%).    El n&uacute;mero de &quot;aciertos&quot; sobre mecanismos de transmisi&oacute;n    y pr&aacute;cticas de prevenci&oacute;n vari&oacute; entre 0 y 80%.     <br>   <B>CONCLUSIONES:</B> Los resultados sugieren que se debe invertir m&aacute;s    en la difusi&oacute;n de conocimientos sobre hepatitis viral, su transmisi&oacute;n    sexual y por el uso de drogas inyectables. El texto completo en ingl&eacute;s    de este art&iacute;culo tambi&eacute;n est&aacute; disponible en: <a href="http://www.insp.mx/salud/index.html">http://www.insp.mx/salud/index.html</a></font></p>     <p><font size="2" face="Verdana"><b>Palabras clave:</b> hepatitis viral; conocimiento;    pr&aacute;cticas preventivas; Brasil </font></p> <HR size="1" noshade>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"> Although epidemiologic surveillance has long    recognized viral hepatitis (VH) as a serious public health problem in Brazil,<SUP>1</SUP>    information on this subject is not widely disseminated. Due to the frequency    of asymptomatic infections, the population largely ignores hepatitis as a serious    disease. </font> </p>     <p><font size="2" face="Verdana"> It is known that the prevalence of hepatitis    A virus (HAV) infection in people over 20 years of age can reach over 90% in    some areas.<SUP>2-4</SUP> Hepatitis B virus (HBV) infection –which affects 300    million chronically infected people worldwide– can reach a prevalence of 10%    among blood donors<SUP>5</SUP> in southern and southeast states of Brazil, and    values above 80% in the western area of the Amazon basin.<SUP>6,7</SUP> Even    more alarming is the finding of prevalences of HBV infection –a sexually transmitted    disease– around 9% among adolescents.<SUP>8</SUP> Hepatitis delta virus (HDV)    co-infection or superinfection –which accelerates and worsens the course of    HBV infection, has been found in the western Amazon, where up to 66.7% of the    HBV infected can also have HDV.<SUP>9</SUP> About 70% to 80% of HBV and HDV    chronically infected persons develop cirrhosis, compared with 10% to 15% of    the HBV-only affected people.<SUP>10</SUP> There are about 170 million people    chronically infected with the hepatitis C virus (HCV) in the world and every    year 3 to 4 million new infections appear.<SUP>11</SUP> Brazil presents prevalence    estimates between 0.6% and 5.9% in blood donors, with values of 2.6% in Rio    de Janeiro.<SUP>12</SUP> A 69.5% prevalence has been reported in intravenous    drug addicts.<SUP>13</SUP> Even though it is the leading cause of chronic liver    disease (85%) in those infected and currently is the largest cause of hepatic    transplant, it took more than 10 years to recognize the impact of HBV infection,    perhaps because of its slow clinical evolution.<SUP>10</SUP> Dissemination of    HAV outbreaks and the increase of the burden of the disease with the change    of the mean age of incidence, contribute to the rise of the indirect costs from    work absenteeism and of medical care costs.<SUP>14</SUP> Additionally, the high    cost and the low effectiveness of treatment for chronic cases of hepatitis B    and C emphasize the importance of making the population aware of the need for    preventive practices. The lay public's knowledge of this problem has been shown    to be insufficient.<SUP>15</SUP> The effectiveness of the actions for disease    prevention and control depends on the ready access to medical resources and    on the behavior of the public in relation to the proposed preventive measures.    The demand for vaccines, use of condoms, access to proper drinking water, quality    blood products, and sterile medical and dentistry procedures has been associated    with appropriate knowledge of the risks of developing diseases, making the dissemination    of information a powerful tool of epidemiological surveillance.<SUP>16</SUP></font></p>     <p><font size="2" face="Verdana"> In a study on the preventive practices of elementary    and high school students in the city of Rio de Janeiro, a significant lack of    knowledge was found regarding important aspects of hepatitis transmission and    prevention.<SUP>15</SUP> Despite many seroprevalence studies, the literature    shows a scarcity of research on general information about the etiology, transmission,    and prevention of viral hepatitis. This study aims at assessing the knowledge    of elementary school teachers on prevention of viral hepatitis infections. </font></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p><font size="3" face="Verdana"><b>Material and Methods </b></font></p>     <p><font size="2" face="Verdana">A cross-sectional pilot study was conducted from    August to November, 1999, in three state capital cities of different areas (north,    northeast and southeast) of Brazil, to assess cultural differences regarding    knowledge on VH transmission and prevention. The data collection instrument    used was an anonymous questionnaire with open questions. In addition to social    and demographic characteristics (age, sex, and neighborhood) of the subjects,    questions on transmission and practices for prevention of hepatitis were included.    Subjects were elementary school teachers registered at pedagogy courses in the    cities of Natal (northeast), Rio de Janeiro (southeast), and Bel&eacute;m (north).    Teachers were chosen from randomly selected public schools. In all three cities,    teachers who were present in days selected at random by the researcher (Bel&eacute;m)    or scheduled for an interview by school authorities were interviewed. The application    of the instrument lasted 30 minutes on average. Written informed consent was    obtained from each participant prior to the <a name="tx01"></a>interview.<SUP>17,</SUP><a href="#nt01">*</a></font></p>     <p><font size="2" face="Verdana"> Data were tabulated and analyzed using EPIINFO    6.04; open answers were classified according to semantic content.<SUP>18</SUP>    The frequencies of information categories on transmission and preventive practices    were interpreted according to the degree of knowledge on viral hepatitis. The    unit of analysis of the frequencies referred to the answers for each category,    since the questions allowed the identification of more than one answer for each    subject in each item. Comparisons of the answer frequencies among cities was    assessed with the chi-square test. The contents of categories of transmission    and preventive practices are defined in <a href="#tab01">Table I</a>. </font></p>     <p><a name="tab01"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/spm/v45n4/a02tab01.gif"></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"> Knowledge of the subjects in relation to the    correct answers to the questions was assessed using quantitative values assigned    to &quot;right&quot; or &quot;wrong&quot; scores for each answer. Five items    were considered for analyzing answers: a &quot;right&quot; score was assigned    to correct information on transmission through food-and water, blood, sexual    intercourse, vertical, and person to person. For prevention, a &quot;right&quot;    score was assigned to correct information on transmission regarding access to    quality drinking water and food, blood transfusions, safe sex practices, immunization,    and personal and environmental care (e.g., avoiding contact with feces). Results    from this pilot study, though not allowing direct inferences on the whole population,    are very valuable for designing further studies including other regions and    groups. </font></p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana"><b>Results </b></font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana">The study sample was composed of 360 subjects    (334 females and 26 males); 81 (22.5%) were from Bel&eacute;m, 123 (34.2%) from    Natal, and 156 (43.3%) from Rio de Janeiro. Ages varied from 18 to 58 years,    with a mean of 32.5 years, a median of 31, and a mode of 21 years. The age distribution    of the sample in the three cities was similar for Rio de Janeiro and Natal.    In Bel&eacute;m, although the age limits are similar, the mean and medium ages    were higher than in the other two cities, and the mode was almost two (1.8)    times larger. </font></p>     <p><font size="2" face="Verdana"> For the global sample (360 subjects) in the    three cities a total of 837 answers were obtained for the transmission category    and 771 for the prevention category. The results of questionnaire responses    are shown in <a href="#tab02">Table II</a>. </font></p>     <p><a name="tab02"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/spm/v45n4/a02tab02.gif"></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"> The &quot;food-and waterborne&quot; item was    the most frequently referred to (around 40%), in the transmission category,    followed by: bloodborne (15.5%), uninformed (10.8%) and inadequate knowledge    with the same percentage values as the possible causes of hepatic disease (8.7%).    Sexual transmission was in the last place with 7.3% (<a href="#tab02">table    II</a>). </font></p>     <p><font size="2" face="Verdana"> For the prevention categories, the &quot;food-    and waterborne&quot; item was predominant (39.9%), followed by the &quot;general    aspects of prevention&quot; (13.2%) and &quot;others/not informed&quot; (10.4%)    items. &quot;Immunization&quot; came next with 9.5% of the references, followed    by &quot;relevance of blood and health services quality&quot; with 7.8%. &quot;Sexual    prevention&quot; came in sixth place with 4.5% (<a href="#tab02">Table II</a>).    </font></p>     <p><font size="2" face="Verdana"> The score of correct answers regarding transmission    mechanisms in the 360 subjects varied from zero to 80%; 35.3% (<I>n</I>=127)    of the subjects scored only 20%; 27.8% (<I>n</I>=100) reached 40%, and 9.4%    (<I>n</I>=34) scored 60% (<a href="#tab03">Table III</a>). Ninety-six (26.7%)    had no correct answers and only three (0.8%) had 80% of correct answers, while    no one attained a score of 100%. The percentage of correct answers on prevention    practices in the 360 subjects also varied from zero to 80%: 33.6% (<I>n</I>=121)    of subjects had only 20%; 22.2% (<I>n</I>=80) scored 40%; and 5% (<I>n</I>=18)    reached 60%. One hundred thirty eight subjects (38.3%) had no correct answers,    three (0.8%) scored 80%, and no one attained a score of 100%. </font></p>     <p><a name="tab03"></a></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p align="center"><img src="/img/revistas/spm/v45n4/a02tab03.gif"></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"> Data were stratified by city to detect possible    differences in data collection. <a href="#tab02">Table II</a> shows the distribution    in Bel&eacute;m, Natal, and Rio de Janeiro, of contents on the transmission    of viral hepatitis according to the categories shown in <a href="#tab01">Table    I</a>. The &quot;food-and waterborne&quot; item was the most frequently mentioned    (38.9%) in Bel&eacute;m, followed by &quot;possible causes of hepatic disease&quot;    (15.9%), and &quot;general aspects of the transmission of diseases&quot; (10.6%)    items. In Natal, &quot;food- and waterborne&quot; showed a value of 33.5%, &quot;bloodborne&quot;    16.3%, and &quot;general aspects of transmission of diseases&quot; 8.8%. In    Rio de Janeiro, the &quot;food- and waterborne&quot; item reached a percentage    of 45.8%, followed by &quot;bloodborne&quot; with 18.6%, and &quot;inadequate    knowledge&quot; with 10.6%. </font></p>     <p><font size="2" face="Verdana"> The distribution of the categories concerning    the practices of prevention of viral hepatitis in Bel&eacute;m, Natal, and Rio    de Janeiro is shown in <a href="#tab02">Table II</a>. In Bel&eacute;m, the &quot;food-    and waterborne&quot; item reached 43.3%, followed by &quot;general aspects of    prevention&quot; (12.9%), and &quot;immunization&quot; (10.5%). In Natal, the    &quot;food-and waterborne&quot; item obtained 33.9% of the answers, &quot;general    aspects of the prevention&quot; 14.3%, and &quot;immunization&quot; 8.7%. In    Rio de Janeiro, the following results were observed: &quot;food-and waterborne&quot;    category (42%), &quot;general aspects of prevention&quot; (12.7%), and &quot;blood    and health services quality&quot; (10.6%) (<a href="#tab02">Table II</a>). </font></p>     <p><font size="2" face="Verdana"> Stratification of the number of correct answers    by city showed that in relation to knowledge on transmission and means of prevention,    the variation of the percentage of correct answers was between 0 and 80%. The    percentile distribution of correct answers by city is shown in <a href="#tab03">Table    III</a>. </font></p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana"><b>Discussion </b></font></p>     <p><font size="2" face="Verdana">Four discrepancies in answers of subjects were    significant: the smaller percentage of references to the &quot;food-and waterborne&quot;    transmission item in Natal (33.9%) in relation to Bel&eacute;m (43.3%), and    Rio de Janeiro (42%); the low percentage of references to &quot;bloodborne prevention&quot;    in Bel&eacute;m (4.3%) as compared with Rio (10.6%) and Natal (7%); the reduced    reference to &quot;general aspects of prevention of diseases&quot; in Rio de    Janeiro (0.9%) relative to Bel&eacute;m (5.7%) and Natal (3.5%); and the &quot;relevant    misinformation or abstinence&quot; in Natal (17.4% against 7.6% in Rio de Janeiro,    and 7.1% in Bel&eacute;m). </font></p>     <p><font size="2" face="Verdana"> The &quot;food-and waterborne&quot; transmission    and the &quot;prevention through sanitation and drinking water supply&quot;    items seemed to be better known than the other items, as shown by the 40% of    references to these items. However, some differences were observed among cities.    The water component of this category was referred to significantly more often    in Rio than in other cities (<font face="symbol">c</font><SUP>2</SUP>=9.63,    <I>p</I>=0.008). Moreover, in relation to the prevention category, the sanitation    component was not mentioned at all in Natal. It is interesting, however, to    observe that in terms of drinking water supply and sewerage, 85.1% of the population    in Rio de Janeiro have access to water and 85.1% have sewerage systems, while    in Natal 77.7% have access to drinking water and 42.4 have sewerage systems)<SUP>19</SUP>.    Study subjects, mainly those of Natal, seemed unable to fully recognize the    relevance of this deficiency of urban infrastructure and/or they did not relate    it to the acquisition or prevention of VH. </font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana"> Although 15.5% of study subjects referred to    bloodborne transmission, they mentioned the control of quality of blood and    health services less often (7.8%). In Rio de Janeiro, blood was mentioned more    frequently than in the other cities, the difference for Bel&eacute;m being statistically    significant (<font face="symbol">c</font><SUP>2</SUP>=8.51 and <I>p</I>=0.014),    possibly linked to the broader diffusion of information and public impact of    contamination of blood with HIV in the 1980s, in Rio de Janeiro. </font></p>     <p><font size="2" face="Verdana"> Desaggregating the bloodborne item of transmission    in its several components, it was observed that the component &quot;use of injected    drugs&quot; was only mentioned in 0.2% of the answers and when reference to    prevention related to the use of syringes was made it was commonly linked to    dental and medical practices. Remarkably, only in Natal reference was made to    this important transmission vehicle. </font></p>     <p><font size="2" face="Verdana"> Although discrepancy between information concerning    the modes of transmission and recommendations on prevention has been observed    in several occasions, the contrast in the blood category is noteworthy. If reference    to the transfusion transmission could suggest people's indignation concerning    this source of contamination, the reminder in smaller scale in respect to prevention    could reflect detachment from the problem, seeing the control of the quality    of blood as a government action not susceptible of modifications through the    participation of the civil society. </font></p>     <p><font size="2" face="Verdana"> Lack of knowledge in the role of sexual transmission    was remarkable. Only in 7.3% of the answers was sex referred to as a way of    transmission and even less often (4.5%) was it mentioned regarding prevention.    Although sexual transmission was mentioned more frequently in Rio de Janeiro    (8.3%) than in the other cities (6.6% in Bel&eacute;m and 6.4% in Natal), this    difference was not significant (<font face="symbol">c</font><SUP>2</SUP>=1.03    and <I>p</I>=0.596). This reflects scarce    knowledge, probably because this topic has received little media coverage. </font></p>     <p><font size="2" face="Verdana"> The appropriation of knowledge was shown to    be inadequate in relation to transmission (9.4%) and to prevention (4.5%). In    this category, it was found that there is great concern about the use of utensils,    such as dishes, glasses, and silverware used by diseased people. It was also    mentioned, however infrequently, that kissing should be avoided to prevent viral    hepatitis transmission. The belief that the use of utensils contaminated by    infected persons, especially those that come into contact with the mouth, urine,    and feces, is largely diffused in our society. This may have a common origin    in the impregnation of the collective imaginary with information that some diseases,    such as tuberculosis, can be transmitted in this way. Another contributing factor    could be the popularization, in the media, of mistaken interpretations of research    results about contamination with fecal coliforms of bar and restaurant utensils,    which usually results from use of contaminated water and not from being handled    by diseased persons. In the category denominated &quot;general aspects of the    transmission of diseases&quot;, food, inadequate lifestyle and insufficient    environmental airing were mentioned as ways facilitating transmission (8.0%)    and as prevention methods(13.2%). Unlike findings for other items, the general    aspects of prevention were mentioned more often than transmission. Among the    cities, it was observed that this category was mentioned least often in Rio    de Janeiro, compared to the other cities (<font face="symbol">c</font><SUP>2</SUP>=4.6    and <I>p</I>=0.1). For the prevention category, the component of environmental    airing seemed to pervade the answers; a curious fact considering that viral    hepatitis infections are not transmitted through the air and, therefore, cannot    be prevented in this way. The quality of life component was mentioned by 6.7%    of the subjects as a preventive measure; it denotes the value that has been    attributed to life conditions and reflects its relationship with health. </font></p>     <p><font size="2" face="Verdana"> Becoming infected with a disease was frequently    associated with behavior lacking prevention measures. Although the caloric or    qualitative content of foods does not interfere directly in the transmission    or prevention of the viral hepatitis, medical recommendations about the type    and amount of fat intake allowances are given to the patients. However, these    recommendations end up constituting a collection of self-imposed limitations    by healthy people. On the other hand, irresponsible lifestyles and inadequate    personal hygiene are regarded as causing disease. </font></p>     <p><font size="2" face="Verdana"> Vaccination was mentioned in 9.6% of the answers,    although most of the time it seems to refer to a general knowledge on the importance    of this practice in disease prevention. However statistically insignificant,    the percentage of references on prevention by immunization was higher in Bel&eacute;m    (10.5%) than in Rio (9.4%) and Natal (8.7%). This may be due to the proximity    to the Delta (Western Amazon) area of high endemicity for hepatitis B, where    there is ample information on the existence of vaccines against viral hepatitis. </font></p>     <p><font size="2" face="Verdana"> Relative misinformation about transmission was    observed in 10.8% and about prevention in 10.4%. This was acknowledged by study    subjects themselves, who then demanded educational campaigns. Natal showed the    highest misinformation percentage, being significantly higher than in the other    cities in relation to transmission (<font face="symbol">c</font><SUP>2</SUP>=31.9    and <I>p</I>&lt;0.0001) and to prevention (<font face="symbol">c</font><SUP>2</SUP>=17.37    and <I>p</I>=0.0002). An interpretation for this could be that the popularization    of information through the media is larger in Rio de Janeiro than in the other    capitals. Moreover, there are no non-governmental organizations contributing    to disseminate social concern on the problem of VH in Natal and Bel&eacute;m<SUP>20</SUP>. </font></p>     <p><font size="2" face="Verdana"> Alcoholic beverages, fat, medicines, and toxic    substances were also referred to as ways of acquiring hepatitis and, in consequence,    avoiding them was referred to as a form of prevention. In Bel&eacute;m, this    category (especially drinking) was mentioned more often than in the other cities    (<font face="symbol">c</font><SUP>2</SUP>=22.2 and <I>p</I>&lt;0.0001) as a    cause of hepatitis. The same finding was observed for the prevention categories    concerning this item (<font face="symbol">c</font><SUP>2</SUP>=10.54 and <I>p</I>=0.005).</font></p>     <p><font size="2" face="Verdana"> Only 10.2% of the 360 subjects scored 60% or    80% correct answers on transmission, as did 5.8% for the prevention category.    These figures confirm previous findings on knowledge concerning these aspects.    They also confirm the observed knowledge deficiencies and the need for greater    dissemination of information on this important topics. Natal presented the higher    percentage of blank or null answers, both for information on the routes of transmission    (44.7%) (<font face="symbol">c</font><SUP>2</SUP>=34.56 and <I>p</I>&lt;0.0001)    and modes of prevention (57.7%) (<font face="symbol">c</font><SUP>2</SUP>=31.05    and <I>p</I>&lt;0.0001). As for the 20, 40, or 60% scores of the two questions,    Natal also showed consistently lower percentages when compared with the other    cities, although these differences were significant only for 40% scores on the    question about routes of transmission (c<SUP><font face="symbol">2</font></SUP>=12.17    and <I>p</I>&lt;0.002) and for 20% scores on the question about prevention (<font face="symbol">c</font><SUP>2</SUP>=9.31    and <I>p</I>&lt;0.009). </font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana"> Teachers' knowledge seems to be inadequate and    inefficient for attaining effective prevention practices against viral hepatitis.    Interviewees' self acknowledgement of the need for information was evident,    pointing to the need for investment in actions to disseminate    appropriate knowledge on viral hepatitis and collaboration with schools to prepare    teachers to promote prevention of VH. </font></p>     <p><font size="2" face="Verdana"> Information on sexual transmission and intravenous    drug use transmission is especially important, for teachers work directly with    youths and are able to disseminate information. Beliefs leading to excessive    concern with patients' utensils reveal inadequate appropriation of knowledge    on fecal-oral, blood, and sexual transmission. </font></p>     <p><font size="2" face="Verdana"> The following findings merit in-depth research    using focal studies: the scarce knowledge of the existence of vaccines against    hepatitis A and B; the failure to recognize intravenous drug use as transmission    vehicles in Rio de Janeiro and in Bel&eacute;m; and the reduced understanding    concerning the relevance of the quality of water and good sanitary conditions,    especially in Natal and Bel&eacute;m. </font></p>     <p><font size="2" face="Verdana"> Studies and interventions are recommended to    make possible the diffusion of information on viral hepatitis, inducing positive    changes in the appropriation of this knowledge. </font></p>     <p>&nbsp;</p>     <p><b><font size="3" face="Verdana">References </font></b></p>     <!-- ref --><p><font size="2" face="Verdana">1. Minist&eacute;rio da Sa&uacute;de. Funda&ccedil;&atilde;o    Nacional de Sa&uacute;de. CENEPI &#91;Editorial&#93;. <I>Boletim Epidemiol&oacute;gico</I>    Out. 1996;<I>I</I>(10):2. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170003&pid=S0036-3634200300040000200001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">2. Clemens SA, da Fonseca JC, Azevedo T, Cavalcanti    A, Silveira TR, Castilho MC <I>et al.</I> Hepatitis A and hepatitis B seroprevalence    in 4 centers in Brazil. <I>Rev Soc Bras Med Trop</I> 2000;<I>33</I>(1):1-10. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170004&pid=S0036-3634200300040000200002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">3. Gaze R. <I>Hepatites Virais: Alfabeto Submerso</I>.    Disserta&ccedil;&atilde;o de Mestrado. N&uacute;cleo de Estudos de Sa&uacute;de    Coletiva/UFRJ. Rio de Janeiro, 1999. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170005&pid=S0036-3634200300040000200003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">4. Miranda LVG, Passos ADC, Figueiredo JFC, Gaspar    AMC, Yoshida CF. Preval&ecirc;ncia de anticorpos contra hepatite A em popula&ccedil;&atilde;o    submetida &agrave; coleta de sangue em unidades de sa&uacute;de. <I>In</I>:    IV Congresso Brasileiro de Epidemiologia. <I>Livro de Resumos</I>. 1998;Rio    de Janeiro 235 (Poster 0306). </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170006&pid=S0036-3634200300040000200004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">5. Treitinger A, Spada C, Ferreira LA, Neto MS,    Reis M, Verdi JC <I>et al</I>. Hepatitis B and hepatitis C prevalence among    blood donors and HIV-1 infected patients    in Florian&oacute;polis - Brazil. <I>Braz J Infect Dis</I> 2000;<I>4</I>(4): 192-6. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170007&pid=S0036-3634200300040000200005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">6. World Health Organization. Expanded Programme    on Immunization: Hepatitis B vaccine - making global progress. Ginebra: WHO,    1996. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170008&pid=S0036-3634200300040000200006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">7. Bensabath G, Hadler SC, Soares MCP, Fields    H, Maynard JE. </font><font size="2" face="Verdana">Caracter&iacute;sticas serol&oacute;gicas    y epidemiol&oacute;gicas de la hepatitis v&iacute;rica aguda en la cuenca amaz&oacute;nica    del Brasil. <I>Bol Oficina Sanit Panam</I> 1987;<I>103</I>(4):351-362. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170009&pid=S0036-3634200300040000200007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">8. Oliveira LHS, Silva IR, Xavier BLS, Cavalcanti    SMB. Hepatitis B infection among patients attending a sexually transmitted diseases    clinic in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 2001;96(5):635-640. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170010&pid=S0036-3634200300040000200008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">9. Paula VS, Arruda ME, Vitral CL, Gaspar AMC.    Seroprevalence of viral hepatitis in riverine communities from the Western Region    of the Brazilian Amazon Basin. Mem Inst Oswaldo Cruz 2001;96(8):1123-1128. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170011&pid=S0036-3634200300040000200009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">10. Centers for Disease Control and Prevention.    <I>Epidemiology and Prevention of Viral Hepatitis A to E: An Overview.</I> Hepatitis    Branch Homepage, Atlanta. Disponible en: <a href="http://www.cdc.gov/ncidod/diseases/hepatitis/hepatitis.htm">http://www.cdc.gov/ncidod/diseases/hepatitis/hepatitis.htm</a>,    Update 19/05/99. 1999. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170012&pid=S0036-3634200300040000200010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">11. World Health Organization. <I>Hepatitis C</I>.    Fact Sheet Nº.164. Disponible en<I>: <a href="http://www.who.int/inf-fs/en/fact164.html">http://www.who.int/inf-fs/en/fact164.html</a></I>,    Oct., 2000. Consultada el 22 de mayo de 2001. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170013&pid=S0036-3634200300040000200011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">12. Sociedade Brasileira de Hepatologia. Epidemiologia    da Infec&ccedil;&atilde;o pelo v&iacute;rus da hepatite C no Brasil. Dispnible    en: <a href="http://www.sbhepatologia.org.br/">http://www.sbhepatologia.org.br/</a>,    1999. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170014&pid=S0036-3634200300040000200012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">13. Oliveira ML, Bastos FI, Telles PR, Yoshida    CF, Schatzmayr HG, Paetzold U <I>et al</I>. Prevalence and risk factors for    HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro,    Brazil. <I>Braz J Med Biol Res</I> 1999;<I>32</I>(9):1107-14. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170015&pid=S0036-3634200300040000200013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">14. Lemon SM. Inactivated hepatitis A virus vaccines.    &#91;Editorial&#93; <I>Hepatology</I> 1992;<I>15</I>(6):1194-7, 1992. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170016&pid=S0036-3634200300040000200014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">15. Gaze R, Affonso KC, Arany C, Carvalho DM,    Tura LFR. Informa&ccedil;&atilde;o e percep&ccedil;&atilde;o de risco sobre    hepatites virais: um estudo com escolares. <I>Cadernos Sa&uacute;de Coletiva</I>    1997;<I>5</I>(2):57-70. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170017&pid=S0036-3634200300040000200015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">16. Fischmann A. Vigil&acirc;ncia Epidemiol&oacute;gica.    <I>En:</I> Rouquayrol MZ, ed. <I>Epidemiologia &amp; Sa&uacute;de</I>. 4a. ed.    Rio de Janeiro: MEDSI, 1993;421-441, 1993. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170018&pid=S0036-3634200300040000200016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">17. Conselho Nacional de Sa&uacute;de. Brasil.    Resolu&ccedil;&atilde;o No. 196 de 10 de outubro de 1996: &quot;Aprova diretrizes    e normas regulamentadoras de pesquisas envolvendo seres humanos&quot;. <I>Cadernos    de &Eacute;tica em Pesquisa</I> 1998;<I>1</I>(1):34-46. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170019&pid=S0036-3634200300040000200017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">18. Bardin L. An&aacute;lise de conte&uacute;do.    Lisboa: Edi&ccedil;&otilde;es 70, 1979. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170020&pid=S0036-3634200300040000200018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">19. Minist&eacute;rio da Sa&uacute;de. DATASUS.    <I>Indicadores e Dados B&aacute;sicos –Brasil– 1998</I>. IBGE – PNAD. Disponible    en:<a href="http://www.datasus.gov.br">http://www.datasus.gov.br</a>.    28/11/2000. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170021&pid=S0036-3634200300040000200019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">20. Varaldo C. Convivendo com a hepatite C: Experi&ecirc;ncias    e informa&ccedil;&otilde;es de um portador do v&iacute;rus. S/ Editora, 2000:268. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9170022&pid=S0036-3634200300040000200020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>&nbsp;</p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"><b>Address reprint requests to</b>    <br>   Rosangela Gaze. R. Teodoro da Silva    ]]></body>
<body><![CDATA[<br>   751 ap. 504. Bloco 02. Vila Isabel    <br>   Rio de Janeiro. RJ. Brasil. CEP: 20560-000    <br>   E-mail: <a href="mailto:rgaze@nesc.ufrj.br">rgaze@nesc.ufrj.br</a></font></p>     <p><font size="2" face="Verdana"><B>Received on:</B> June 20, 2002<B>    <br>   Accepted on</B>: February 26, 2003 </font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"><a name="nt01"></a><a href="#tx01">*</a> This    study met the requirements of the National Council of Health Deliberation nº    196/96, and was approved by the Ethical Committee in Human Research of the N&uacute;cleo    de Estudos de Sa&uacute;de Coletiva of the Federal University of Rio de Janeiro    (Brazil, 1998).</font></p>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<collab>Ministério da Saúde^dFundação Nacional de Saúde</collab>
<article-title xml:lang="pt"><![CDATA[CENEPI [Editorial].]]></article-title>
<source><![CDATA[Boletim Epidemiológico Out.]]></source>
<year>1996</year>
<volume>I</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>2</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clemens]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[da Fonseca]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Azevedo]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Cavalcanti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Silveira]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
<name>
<surname><![CDATA[Castilho]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Hepatitis A and hepatitis B seroprevalence in 4 centers in Brazil]]></article-title>
<source><![CDATA[Rev Soc Bras Med Trop]]></source>
<year>2000</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaze]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Hepatites Virais: Alfabeto Submerso]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[LVG]]></given-names>
</name>
<name>
<surname><![CDATA[Passos]]></surname>
<given-names><![CDATA[ADC]]></given-names>
</name>
<name>
<surname><![CDATA[Figueiredo]]></surname>
<given-names><![CDATA[JFC]]></given-names>
</name>
<name>
<surname><![CDATA[Gaspar]]></surname>
<given-names><![CDATA[AMC]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshida]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Prevalência de anticorpos contra hepatite A em população submetida à coleta de sangue em unidades de saúde]]></article-title>
<source><![CDATA[]]></source>
<year></year>
<conf-name><![CDATA[IV Congresso Brasileiro de Epidemiologia. Livro de Resumos]]></conf-name>
<conf-date>1998</conf-date>
<conf-loc>Rio de Janeiro </conf-loc>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Treitinger]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Spada]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Neto]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Reis]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Verdi]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianópolis - Brazil]]></article-title>
<source><![CDATA[Braz J Infect Dis]]></source>
<year>2000</year>
<volume>4</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>192-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Expanded Programme on Immunization: Hepatitis B vaccine - making global progress]]></source>
<year>1996</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bensabath]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Hadler]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Soares]]></surname>
<given-names><![CDATA[MCP]]></given-names>
</name>
<name>
<surname><![CDATA[Fields]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Maynard]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Características serológicas y epidemiológicas de la hepatitis vírica aguda en la cuenca amazónica del Brasil]]></article-title>
<source><![CDATA[Bol Oficina Sanit Panam]]></source>
<year>1987</year>
<volume>103</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>351-362</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[LHS]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[IR]]></given-names>
</name>
<name>
<surname><![CDATA[Xavier]]></surname>
<given-names><![CDATA[BLS]]></given-names>
</name>
<name>
<surname><![CDATA[Cavalcanti]]></surname>
<given-names><![CDATA[SMB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Hepatitis B infection among patients attending a sexually transmitted diseases clinic in Rio de Janeiro, Brazil]]></article-title>
<source><![CDATA[Mem Inst Oswaldo Cruz]]></source>
<year>2001</year>
<volume>96</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>635-640</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paula]]></surname>
<given-names><![CDATA[VS]]></given-names>
</name>
<name>
<surname><![CDATA[Arruda]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Vitral]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Gaspar]]></surname>
<given-names><![CDATA[AMC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Seroprevalence of viral hepatitis in riverine communities from the Western Region of the Brazilian Amazon Basin]]></article-title>
<source><![CDATA[Mem Inst Oswaldo Cruz]]></source>
<year>2001</year>
<volume>96</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1123-1128</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<collab>Centers for Disease Control and Prevention</collab>
<source><![CDATA[Epidemiology and Prevention of Viral Hepatitis A to E: An Overview. Hepatitis Branch Homepage]]></source>
<year>1999</year>
<publisher-loc><![CDATA[Atlanta ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[Hepatitis C. Fact Sheet Nº.164]]></source>
<year>2001</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<collab>Sociedade Brasileira de Hepatologia</collab>
<source><![CDATA[Epidemiologia da Infecção pelo vírus da hepatite C no Brasil]]></source>
<year>1999</year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Bastos]]></surname>
<given-names><![CDATA[FI]]></given-names>
</name>
<name>
<surname><![CDATA[Telles]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshida]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Schatzmayr]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
<name>
<surname><![CDATA[Paetzold]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil]]></article-title>
<source><![CDATA[Braz J Med Biol Res]]></source>
<year>1999</year>
<volume>32</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1107-14</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lemon]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Inactivated hepatitis A virus vaccines]]></article-title>
<source><![CDATA[[Editorial] Hepatology]]></source>
<year>1992</year>
<volume>15</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1194-7, 1992</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaze]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Affonso]]></surname>
<given-names><![CDATA[KC]]></given-names>
</name>
<name>
<surname><![CDATA[Arany]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Tura]]></surname>
<given-names><![CDATA[LFR]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Informação e percepção de risco sobre hepatites virais: um estudo com escolares]]></article-title>
<source><![CDATA[Cadernos Saúde Coletiva]]></source>
<year>1997</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>57-70</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fischmann]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Vigilância Epidemiológica]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Rouquayrol]]></surname>
<given-names><![CDATA[MZ]]></given-names>
</name>
</person-group>
<source><![CDATA[Epidemiologia & Saúde]]></source>
<year>1993</year>
<edition>4</edition>
<page-range>421-441</page-range><publisher-loc><![CDATA[Rio de Janeiro ]]></publisher-loc>
<publisher-name><![CDATA[MEDSI, 1993]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<collab>Brasil^dConselho Nacional de Saúde</collab>
<article-title xml:lang="pt"><![CDATA[Resolução No. 196 de 10 de outubro de 1996: "Aprova diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos"]]></article-title>
<source><![CDATA[Cadernos de Ética em Pesquisa]]></source>
<year>1998</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>34-46</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bardin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Análise de conteúdo]]></source>
<year>1979</year>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[Edições 70]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="">
<collab>Ministério da Saúde^dDATASUS</collab>
<source><![CDATA[Indicadores e Dados Básicos: Brasil- 1998. IBGE - PNAD]]></source>
<year>28/1</year>
<month>1/</month>
<day>20</day>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Varaldo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Convivendo com a hepatite C: Experiências e informações de um portador do vírus]]></source>
<year>2000</year>
<page-range>268</page-range><publisher-name><![CDATA[S/ Editora]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
